A recent study by Wesselink et al. (Am J Epidemiol. 2022 Jan 20;kwac011. doi: 10.1093/aje/kwac011. Online ahead of print) adds to the growing body of research finding that vaccination for coronavirus disease 2019 (COVID-19) is safe for individuals either seeking pregnancy or who are pregnant. The study’s authors found no effect of COVID-19 vaccination on fecundity in a population of individuals with no known infertility who were attempting conception. The finding reinforces the messaging of the American Society for Reproductive Medicine COVID-19 Task Force, the aim of which is to provide data-driven recommendations to individuals contemplating pregnancy in the face of the COVID-19 pandemic. As safe and effective COVID-19 vaccines became available, and with an increasing number of studies showing a heightened risk of severe disease during pregnancy, an important role of the Task Force is to encourage vaccination during the preconceptual window and in early pregnancy. The Task Force supports ongoing research to address gaps in knowledge about safe and effective therapies and preventive measures for individuals contemplating pregnancy and during pregnancy. Such research will help optimize care for reproductive-age individuals in the face of current and future health crises.

Wesselink 等人最近的一项研究。(美国流行病学杂志. 2022 年 1 月 20 日；kwac011。内政部：10.1093/aje/kwac011。印刷前在线）增加了越来越多的研究发现，2019 年冠状病毒病 (COVID-19) 疫苗接种对于寻求怀孕或已怀孕的个人是安全的。该研究的作者发现 COVID-19 疫苗接种对尝试受孕且没有已知不育症的人群的生育能力没有影响。这一发现强化了美国生殖医学协会 COVID-19 工作组的信息，该工作组的目的是为面对 COVID-19 大流行而考虑怀孕的个人提供数据驱动的建议。随着安全有效的 COVID-19 疫苗的问世，以及越来越多的研究表明怀孕期间患重病的风险增加，工作组的一个重要作用是鼓励在孕前窗口期和妊娠早期接种疫苗。工作组支持正在进行的研究，以解决有关针对计划怀孕和怀孕期间的个人的安全有效疗法和预防措施的知识差距。面对当前和未来的健康危机，此类研究将有助于优化对育龄人群的护理。